Publications by authors named "Dallas Williams"

Claim this Profile
P
Perspectives of Behavioral Health Clinicians in a Rural Integrated Primary Care/Mental Health Program.
Dallas Williams, Jessica Eckstrom, Marc Avery, Jürgen Unützer

J Rural Health· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utility of a caseload registry: perceptions of behavioral health clinicians working in an integrated primary care and mental health program.
Jessica Eckstrom, Dallas Williams, Marc Avery, Jürgen Unützer

Gen Hosp Psychiatry· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.
Arlene O Siefker-Radtke, Colin P Dinney, Yu Shen, Dallas L Williams, Ashish M Kamat

Cancer· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.
Lance C Pagliaro, Dallas L Williams, Danai Daliani, Michael B Williams, William Osai

J Clin Oncol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.
Arlene O Siefker-Radtke, Ashish M Kamat, H Barton Grossman, Dallas L Williams, Wei Qiao

J Clin Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant platelet derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation for high risk localized prostate cancer.
Paul Mathew, Louis L Pisters, Christopher G Wood, John N Papadopoulos, Dallas L Williams

J Urol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
Peter F Thall, Christopher Logothetis, Lance C Pagliaro, Sijin Wen, Melissa A Brown, Dallas Williams

J Natl Cancer Inst· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, alpha-interferon, cisplatin (FAP).
Shi-Ming Tu, Randall E Millikan, Lance C Pagliaro, Danai Daliani, Christos N Papandreou, Dallas L Williams

Urol Oncol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of sequentially applied doublets in poor-prognosis metastatic urothelial cancer.
Dallas Williams, Randall Millikan

Urol Oncol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases.
Lance C Pagliaro, Ebrahim S Delpassand, Dallas Williams, Randall E Millikan, Shi-Ming Tu

Cancer· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.
Lance C Pagliaro, Afsaneh Keyhani, Dallas Williams, Denise Woods, Baoshun Liu

J Clin Oncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma.
Lance C Pagliaro, Randall E Millikan, Shi-Ming Tu, Dallas Williams, Danai Daliani

J Clin Oncol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer.
Arlene O Siefker-Radtke, Randall E Millikan, Shi-Ming Tu, Dennis F Moore, Terry L Smith, Dallas Williams

J Clin Oncol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis